3SBIO 2025 ESG Report: A-Level Rating, 48.49% Cut in Carbon Intensity and Full Anti-Corruption Coverage

Bulletin Express
04/29

3SBIO released its 2025 Environmental, Social and Governance (ESG) Report, receiving an “A” rating from SynTao Green Finance and maintaining a “B” score from CDP’s Climate Change questionnaire for the sixth consecutive year.

Environmental Highlights • Greenhouse-gas emissions intensity dropped 48.49% year-on-year to 0.0380 tCO₂e per RMB10,000 of revenue. • Hazardous-waste intensity fell 56.77% to 0.3881 kg/RMB10,000, while non-hazardous-waste intensity declined 40.44% to 0.2700 kg/RMB10,000. • All operating manufacturing bases hold ISO 14001 certification, and Sunshine Guojian has been named a national-level Green Factory.

Social Indicators • Average training hours reached 21.28 per employee. • Employee turnover rate improved to 20.39%, a 9.83% year-on-year reduction. • Company-wide health and safety efforts resulted in zero work-related fatalities and a decrease in lost-work days to 70.

Governance Metrics • Anti-corruption training coverage hit 100% for both Board members and employees; the Board links remuneration to key ESG indicators. • An ESG Committee, led by directors, oversees strategy while an ESG Working Group executes daily tasks across functions including R&D, manufacturing and marketing.

Climate Strategy • Scenario analysis under NGFS “Net Zero 2050” and IPCC SSP pathways identified typhoons and water scarcity as principal physical risks and projected manageable transition costs. • The firm met its 2025 target of reducing carbon intensity 20% from a 2017 baseline, achieving a 41.54% cut.

Product & Supply Chain • No product recalls were recorded, and complaint handling rate remained at 100%. • 89.51% of suppliers underwent environmental, labor and ethics assessments; 3SBIO advanced localisation and second-source development to strengthen supply resilience.

Stakeholder Engagement • More than 15,100 grassroots medical personnel were trained through the Ankylosing Spondylitis-Based Healthy Village programme, which screened 10,582 patients and provided RMB8.13 million in treatment grants.

The Board of Directors reviews ESG performance at least twice a year and has pledged further emissions, resource-efficiency and waste-reduction targets beyond 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10